Vaccination News Home Page

http://www.portal.telegraph.co.uk/news/main.jhtml?xml=/news/2002/09/01/nmmr01.xml&sSheet=/news/2002/09/01/ixhome.html

| |
news.telegraph.co.uk
Save this page to your clipboard Email this page to a friend Print this page as text only
telegraph.co.uk
News home
Business news
Crossword Society
Feedback
Golden Jubilee
Law reports
Matt cartoon
Obituaries
Opinion
Weather
War on terrorism
About us
Contact us

 
 


 

Disabled children sue over triple diphtheria vaccine
By Rajeev Syal
(Filed: 01/09/2002)
 

The manufacturer of the controversial MMR vaccine is being sued over claims that another of its triple inoculations has caused cerebral palsy and autism in hundreds of British children.

A group of 120 disabled children have joined a class action, which claims that their illnesses were caused by the three-in-one diphtheria, pertussis and tetanus (DPT) vaccine made by Glaxo Wellcome and the Wellcome Foundation.

Glaxo Wellcome is now part of GlaxoSmithKline, the company which is facing a separate claim by several thousand children whose autism was allegedly triggered by the company's measles, mumps and rubella (MMR) vaccine.

The Government has previously admitted that the DPT vaccine can cause problems in some children and paid limited compensation to victims under the 1979 Vaccine Damages Payments Act.

Debbie Murphy of Alexander Harris, a Manchester-based solicitors firm that is leading the class action, said: "We are anxious to prove that a link does exist and we believe that there is enough evidence to mount a case against the manufacturers."

One of the children allegedly harmed by the DPT vaccine is Karl Radunovic, 8, from Wakefield, West Yorkshire, who is suing through his mother, Elizabeth.

Karl was injected with the DPT vaccine when only a few weeks old and immediately reacted badly. Doctors still believed that he was well, but Mrs Radunovic was convinced that there had been a fundamental change in his behaviour.

"The doctors thought I had a lazy child, but I knew that this was not how a baby acts," she said. "I knew that he was ill. He was like a rag doll, his head lolling to one side."

At the age of 18 months, Karl was diagnosed with cerebral palsy. He now needs to be monitored 24 hours a day.

"We want the courts to get to the bottom of all this, and prove that the medical companies should bear some responsibility," she said.

The DPT vaccine is usually given to babies, normally at two, three and four months of age. It consists of dead bacteria and inactive toxins which stimulate a baby's immune system to fight the diseases.

The element of the vaccine known as pertussis, or more commonly whooping cough, has previously been linked with a rise in childhood ailments including asthma and cerebral palsy.

At present, the legal action has been granted legal aid, subject to final approval being given by the Legal Services Commission. A Glaxo SmithKline spokesman declined to comment on any impending litigation.

 

25 August 2002: Parents unhappy with MMR safety experts' links to drug firms
23 August 2002: Research puts MMR autism link in doubt
7 July 2002: Alternative rubella jab to MMR is discontinued
17 May 2002: MMR jabs increase as debate cools off
9 December 2001: Studies fail to disprove autism link to MMR jab

 

Previous story: Swimming chiefs investigate 20 claims of abuse
Next story: Pret A Manger declares crayfish war on EU
 

 
External links  
 
Public health and clinical quality - Department of Health
 
DPT vaccine - Glaxo SmithKline
 
The DPT vaccine - Healing Centre
 
Jabs [anti combined-vaccine site]
 

 

 

 

 

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.